Breaking News Instant updates and real-time market news.

2021-02-22 07:23:54 ALB Albemarle $156.04 / +14.52 (+10.26%) 07:23 02/22/21 02/22 07:23 02/22/21 07:23	Albemarle price target raised to $177 from $140 at Argus Argus analyst Bill Selesky raised the firm's price target on Albemarle to $177 from $140 and keeps a Buy rating on the shares. The company's Q4 earnings per share fell from last year due to weaker results in the Lithium business as a result of lower contract and spot pricing and in the Catalyst division as a result of reduced fuel demand, but its management expects stronger operating performance this year, tracking continued economic recovery, the analyst tells investors in a research note. Selesky adds that he expects the current high lithium inventories to be worked down over the next several months, and he looks for higher pricing in the second half of 2021.	04 Feb
ALB Albemarle $156.04 / +14.52 (+10.26%) 02/16/21 Fly Intel: Top five analyst upgrades 02/16/21 Deutsche Bank Deutsche upgrades Albemarle with lithium earnings ramp 'finally here' 02/15/21 Deutsche Bank Albemarle upgraded to Buy from Hold at Deutsche Bank 02/12/21 Fly Intel: Top five analyst upgrades

2021-02-22 07:23:54

ALB

Albemarle

$156.04 / +14.52 (+10.26%)

07:23

02/22/21

02/22

07:23

02/22/21

07:23

Albemarle price target raised to $177 from $140 at Argus

Argus analyst Bill Selesky raised the firm's price target on Albemarle to $177 from $140 and keeps a Buy rating on the shares. The company's Q4 earnings per share fell from last year due to weaker results in the Lithium business as a result of lower contract and spot pricing and in the Catalyst division as a result of reduced fuel demand, but its management expects stronger operating performance this year, tracking continued economic recovery, the analyst tells investors in a research note. Selesky adds that he expects the current high lithium inventories to be worked down over the next several months, and he looks for higher pricing in the second half of 2021.

04
Feb

ALB Albemarle

$156.04 / +14.52 (+10.26%)

02/16/21: Fly Intel: Top five analyst upgrades

02/16/21 Deutsche Bank: Deutsche upgrades Albemarle with lithium earnings ramp 'finally here'

02/15/21 Deutsche Bank: Albemarle upgraded to Buy from Hold at Deutsche Bank

02/12/21: Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Earnings	Ardelyx reports Q4 EPS (32c), consensus (26c) » 08:03 03/08/21 03/08 08:03 03/08/21 08:03 ARDX Ardelyx $6.68 / +0.005 (+0.07%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ARDX Ardelyx $6.68 / +0.005 (+0.07%) 09/15/20 Ardelyx annonces FDA accepted NDA of Tenapanor ARDX Ardelyx $6.68 / +0.005 (+0.07%) 01/21/21 Piper Sandler Ardelyx remains a top pick into April PDUFA at Piper Sandler 01/05/21 Cantor Fitzgerald Ardelyx initiated with an Overweight at Cantor Fitzgerald 12/11/20 SVB Leerink Ardelyx price target raised to $14 from $11 at SVB Leerink 10/20/20 Citi Ardelyx transferred with Buy rating, $13 target at Citi ARDX Ardelyx $6.68 / +0.005 (+0.07%) 11/05/20 Ardelyx reports Q3 EPS (20c), consensus (28c) ARDX Ardelyx $6.68 / +0.005 (+0.07%) 01/06/21 Fly Intel: Pre-market Movers 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday 04/29/21 PDUFA Date
Hot Stocks	Iqvia collaborates with Janssen on COVID-19 vaccine clinical trials » 08:03 03/08/21 03/08 08:03 03/08/21 08:03 IQV Iqvia $188.91 / +2.44 (+1.31%) , JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) Iqvia (IQV) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IQV JNJ IQV Iqvia $188.91 / +2.44 (+1.31%) 12/21/20 Q2 Solutions teams with Adaptive Biotechnologies to market immunoSEQ Assay 12/16/20 Iqvia in pact with Servier to 'reinvent' its R&D clinical development processes 11/18/20 Iqvia's Rittenmeyer sells over 40,000 common shares 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/05/21 Health Canada authorizes Janssen COVID-19 vaccine 03/04/21 Nemaura Medical appoints Alistair Longmuir as advisor on manufacture strategy 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine 02/28/21 Fly Intel: Top five weekend stock stories IQV JNJ IQV Iqvia $188.91 / +2.44 (+1.31%) 06:40 Today KeyBanc Iqvia upgraded to Overweight from Sector Weight at KeyBanc 03/02/21 Barclays Iqvia initiated with an Overweight at Barclays 03/02/21 Barclays Iqvia initiated with an Overweight at Barclays 02/11/21 Truist Iqvia price target raised to $235 from $197 at Truist JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' IQV JNJ IQV Iqvia $188.91 / +2.44 (+1.31%) 02/10/21 Iqvia raises FY21 adjusted EPS view to $7.77-$8.08 from $7.65-$7.95 02/10/21 Iqvia sees Q1 adjusted EPS $1.81-$1.87, consensus $1.80 02/10/21 Iqvia reports Q4 adjusted EPS $2.11, consensus $2.00 02/09/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/05/21 J&J COVID-19 vaccine approved by Canada's regulator, AP reports 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says IQV JNJ IQV Iqvia $188.91 / +2.44 (+1.31%) 02/10/21 Fly Intel: Pre-market Movers 10/20/20 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 13:00 Today Biopharmaceuticals 04/20/21 Johnson & Johnson - JNJ 04/13/21 IQVIA Holdings Inc. IQV JNJ IQV Iqvia $188.91 / +2.44 (+1.31%) 02/10/21 Early notable gainers among liquid option names on February 10th JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th
Initiation	Bumble initiated with a Buy at Jefferies » 08:02 03/08/21 03/08 08:02 03/08/21 08:02 BMBL Bumble $61.93 / +2.41 (+4.05%) Jefferies analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Events Options BMBL Bumble $61.93 / +2.41 (+4.05%) 08:02 Today Jefferies Bumble initiated with a Buy at Jefferies 07:30 Today JPMorgan Bumble initiated with a Neutral at JPMorgan 07:30 Today Cowen Bumble initiated with an Outperform at Cowen 06:53 Today Morgan Stanley Bumble initiated with an Equal Weight at Morgan Stanley 11 Feb BMBL Bumble $61.93 / +2.41 (+4.05%) 03/04/21 Snowflake, Qualcomm upgrades among today's top calls on Wall Street 02/14/21 Opening Day: Bumble, Viant soar in market debuts 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 03/10/21 Bumble - BMBL BMBL Bumble $61.93 / +2.41 (+4.05%) 02/18/21 Fourteen new option listings and one option delisting on February 18th
Hot Stocks	AnaptysBio says imsidolimab POPLAR Phase 2 trial did not meet primary endpoint » 08:02 03/08/21 03/08 08:02 03/08/21 08:02 ANAB AnaptysBio $29.46 / +1.33 (+4.73%) AnaptysBio announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 07:55 Today AnaptysBio trading halted, news pending 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' 10/26/20 AnaptysBio, GlaxoSmithKline amend strategic immuno-oncology collaboration ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 02/11/21 JPMorgan JPMorgan double upgrades AnaptysBio, more than doubles price target 02/11/21 JPMorgan AnaptysBio upgraded to Overweight from Underweight at JPMorgan 10/27/20 Fly Intel: Top five analyst upgrades 10/27/20 Truist AnaptysBio price target raised to $27 from $20 at Truist ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 02/25/21 AnaptysBio reports Q4 EPS $1.20, consensus $1.39 11/04/20 AnaptysBio reports Q3 EPS (87c), consensus (72c) ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street
Initiation	Lufax initiated with a Buy at Citi » 08:02 03/08/21 03/08 08:02 03/08/21 08:02 LU Lufax $15.24 / +0.01 (+0.07%) Citi analyst Judy Zhang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LU Lufax $15.24 / +0.01 (+0.07%) 11/23/20 Lufax falls -8.3% 11/03/20 Lufax falls -9.8% 11/03/20 Lufax provides updates regarding recent regulatory development LU Lufax $15.24 / +0.01 (+0.07%) 12/11/20 China Renaissance Lufax initiated with a Buy at China Renaissance 11/27/20 HSBC Lufax initiated with a Buy at HSBC 11/24/20 Fly Intel: Top five analyst initiations 11/24/20 Stifel Lufax initiated with a Hold at Stifel LU Lufax $15.24 / +0.01 (+0.07%) 02/02/21 Lufax reports Q4 net profit $436M, up 17.4% from last year 12/01/20 Lufax reports Q3 net profit $318M, down 36.8% from last year 30 Oct LU Lufax $15.24 / +0.01 (+0.07%) 12/01/20 Fly Intel: After-Hours Movers 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut LU Lufax $15.24 / +0.01 (+0.07%) 12/16/20 Largest borrow rate increases among liquid names 12/02/20 One new option listing and two option delistings on December 2nd

Recommendations	Crane price target raised to $100 from $96 at Canaccord » 08:00 03/08/21 03/08 08:00 03/08/21 08:00 CR Crane $89.46 / +2.7 (+3.11%) Canaccord analyst Ken… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly CR Crane $89.46 / +2.7 (+3.11%) 01/07/21 Vertical Research Crane upgraded to Buy with $97 price target at Vertical Research 01/07/21 DA Davidson Crane cut to Neutral at DA Davidson on valuation 01/07/21 DA Davidson Crane downgraded to Neutral from Buy at DA Davidson 10/07/20 DA Davidson DA Davidson positive on Crane's Engineered Materials, PMT segments CR Crane $89.46 / +2.7 (+3.11%) 01/25/21 Crane sees FY21 revenue about $3.05B, consensus $3.13B 01/25/21 Crane guides initial FY21 EPS view of $4.90-$5.10, consensus $4.95 01/25/21 Crane reports Q4 EPS $1.00, consensus $1.10 10/26/20 Crane sees FY20 sales down 17%-19% versus prior view down 17%-21% CR Crane $89.46 / +2.7 (+3.11%) 01/25/21 Fly Intel: After-Hours Movers
Options	NIO call buyer realizes 65% same-day gains » 08:00 03/08/21 03/08 08:00 03/08/21 08:00 NIO NIO $38.13 / -1.135 (-2.89%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options NIO NIO $38.13 / -1.135 (-2.89%) 02/01/21 NIO delivers 7,225 vehicles in January, up 352.1% 01/10/21 Fly Intel: Top five weekend stock stories 01/10/21 Nio partners with Nvidia to develop new generation of automated driving EV 01/03/21 NIO Inc. reports 7,007 vehicle deliveries in December 2020 NIO NIO $38.13 / -1.135 (-2.89%) 03/03/21 Wedbush China growth story worth at least $100/share in bull case to Tesla, says Wedbush 02/26/21 HSBC NIO price target raised to $54 from $44.70 at HSBC 02/09/21 Deutsche Bank NIO job post shows ambitions to enter U.S. market, says Deutsche Bank 01/28/21 Morgan Stanley NIO price target raised to $80 from $33 at Morgan Stanley NIO NIO $38.13 / -1.135 (-2.89%) 03/01/21 NIO sees Q1 revenue $1.13B-$1.16B, consensus $718.49M 03/01/21 NIO reports Q4 adjusted EPS (14c), consensus (7c) 11/17/20 NIO Inc. sees Q4 revenue $921.8M-$947.9M, consensus $805.66M 11/17/20 NIO Inc. reports Q3 adj. EPS (12c), consensus (17c) 14 Dec 31 Aug 11 Jun NIO NIO $38.13 / -1.135 (-2.89%) 01/28/21 NIO ES6 'rumored to be coming to Europe in 2021,' Electrek says 01/06/21 NIO plans to launch models with lithium iron phosphate batteries, CNEVPost says 12/12/20 Nio, Xeng, Li Auto not the next Tesla, Barron's says 12/07/20 QuantumScape battery tech could be 'huge' for EVs, Barron's reports NIO NIO $38.13 / -1.135 (-2.89%) 03/06/21 Charged: GM-backed Cruise said to be in talks to acquire Voyage 03/02/21 Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers 02/24/21 Fly Intel: What to watch in Nvidia earnings report NIO NIO $38.13 / -1.135 (-2.89%) 03/05/21 Notable open interest changes for March 5th 03/03/21 Notable open interest changes for March 3rd 03/02/21 Notable open interest changes for March 2nd 03/01/21 NIO options imply 16.3% move in share price post-earnings
Recommendations	Imara price target lowered to $42 from $59 at SVB Leerink » 07:58 03/08/21 03/08 07:58 03/08/21 07:58 IMRA Imara $10.00 / -2.37 (-19.16%) SVB Leerink analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMRA Imara $10.00 / -2.37 (-19.16%) 03/05/21 Imara to initiate pediatric clinical program of IMR-687 in 1H21 03/05/21 Imara plans to report interim data from Phase 2b IMR-687 trials in 2H21 03/05/21 Imara reports Phase 2a open label extension clinical trial data 03/05/21 Imara expects cash to fund planned operations into mid-2022 IMRA Imara $10.00 / -2.37 (-19.16%) 01/06/21 SVB Leerink Imara selloff a potential buying opportunity, says SVB Leerink 08/17/20 Fly Intel: Top five analyst upgrades 08/17/20 Citi Imara upgraded to Buy from Neutral at Citi 06/30/20 Citi Imara downgraded to Neutral from Buy at Citi IMRA Imara $10.00 / -2.37 (-19.16%) 03/05/21 Imara reports 2020 EPS ($3.53), consensus ($3.82) 11/05/20 Imara reports Q3 EPS (72c), consensus (80c) 12 Mar IMRA Imara $10.00 / -2.37 (-19.16%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day
Downgrade	GSX Techedu downgraded to Sell from Outperform at CLSA » 07:58 03/08/21 03/08 07:58 03/08/21 07:58 GSX GSX Techedu $92.25 / +8.14 (+9.68%) CLSA analyst Jeffrey Chan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSX GSX Techedu $92.25 / +8.14 (+9.68%) 03/05/21 GSX Techedu rises 11.9% 03/05/21 GSX Techedu falls -16.6% 03/03/21 GSX Techedu falls -13.3% 01/13/21 GSX Techedu rises 27.1% GSX GSX Techedu $92.25 / +8.14 (+9.68%) 07:38 Today JPMorgan GSX Techedu price target lowered to $60 from $63 at JPMorgan 02/01/21 JPMorgan GSX Techedu downgraded to Underweight from Neutral at JPMorgan 01/29/21 GSX Techedu downgraded to Sell from Neutral at China Merchants 01/28/21 Goldman Sachs GSX Techedu downgraded to Sell from Neutral at Goldman Sachs GSX GSX Techedu $92.25 / +8.14 (+9.68%) 03/05/21 GSX Techedu sees Q1 revenue up 40%-43% versus last year 03/05/21 GSX Techedu reports Q4 EPS (39c), consensus (38c) 11/20/20 GSX Techedu reports Q3 EPS (57c), consensus (31c) GSX GSX Techedu $92.25 / +8.14 (+9.68%) 12/18/20 Seven whistleblowers have described 'fraud' at GSX Techedu, Aurelius Value says 10/12/20 WSJ article on GSX 'somewhat misses the point,' Muddy Waters says 10/12/20 GSX proves to be one of the year's worst short bets, WSJ says GSX GSX Techedu $92.25 / +8.14 (+9.68%) 03/05/21 Fly Intel: Pre-market Movers 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: Wall Street's top stories for Thursday 01/28/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Media, Internet and Telecom Virtual Conference GSX GSX Techedu $92.25 / +8.14 (+9.68%) 03/04/21 GSX Techedu put volume heavy and directionally bearish 03/03/21 GSX Techedu put volume heavy and directionally bearish 01/21/21 GSX Techedu call volume above normal and directionally bullish 12/28/20 GSX Techedu put volume heavy and directionally bearish
Hot Stocks	AnaptysBio trading halted, news pending 07:55 03/08/21 03/08 07:55 03/08/21 07:55 ANAB AnaptysBio $29.46 / +1.33 (+4.73%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' 10/26/20 AnaptysBio, GlaxoSmithKline amend strategic immuno-oncology collaboration 10/13/20 AnaptysBio reports topline data from GALLOP Phase 2 trial of imsidolimab ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 02/11/21 JPMorgan JPMorgan double upgrades AnaptysBio, more than doubles price target 02/11/21 JPMorgan AnaptysBio upgraded to Overweight from Underweight at JPMorgan 10/27/20 Fly Intel: Top five analyst upgrades 10/27/20 Truist AnaptysBio price target raised to $27 from $20 at Truist ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 02/25/21 AnaptysBio reports Q4 EPS $1.20, consensus $1.39 11/04/20 AnaptysBio reports Q3 EPS (87c), consensus (72c) ANAB AnaptysBio $29.46 / +1.33 (+4.73%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street

Hot Stocks	Baker Bros Advisors report 9.9% stake in Aeglea BioTherapeutics » 07:54 03/08/21 03/08 07:54 03/08/21 07:54 AGLE Aeglea BioTherapeutics $7.21 / +0.06 (+0.84%) In a regulatory 13D… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate AGLE Aeglea BioTherapeutics $7.21 / +0.06 (+0.84%) 02/03/21 Aeglea BioTherapeutics CFO Charles York II to leave for another opportunity 01/05/21 Aeglea pushes back arginase 1 deficiency trial enrollment to March 12/01/20 Aeglea receives FDA Rare Pediatric Disease Designation for ACN00177 10/26/20 Aeglea BioTherapeutics' ACN00177 for homocystinuria designated Orphan Drug AGLE Aeglea BioTherapeutics $7.21 / +0.06 (+0.84%) 01/05/21 H.C. Wainwright Aeglea delays trial enrollment goal by two months, says H.C. Wainwright 12/22/20 Piper Sandler Aeglea BioTherapeutics named a top pick for 2021 at Piper Sandler 08/10/20 Piper Sandler Piper Sandler backs Overweight rating on Aeglea BioTherapeutics after Q2 results 05/04/20 Fly Intel: Top five analyst initiations AGLE Aeglea BioTherapeutics $7.21 / +0.06 (+0.84%) 11/05/20 Aeglea BioTherapeutics reports Q3 EPS (29c), consensus (39c) 28 Apr
Upgrade	Surge Energy upgraded to Buy from Hold at Stifel » 07:52 03/08/21 03/08 07:52 03/08/21 07:52 ZPTAF Surge Energy $0.00 / + (+0.00%) Stifel analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ZPTAF Surge Energy $0.00 / + (+0.00%) 03/07/21 National Bank Surge Energy upgraded to Outperform from Sector Perform at National Bank 02/19/21 National Bank Surge Energy price target raised to C$0.75 from C$0.50 at National Bank 01/28/21 Stifel Surge Energy price target raised to C$0.45 from C$0.40 at Stifel 01/06/21 National Bank Surge Energy price target raised to C$0.50 from C$0.40 at National Bank
Hot Stocks	OpGen announces publication of study results of Unyvero HPN panel » 07:51 03/08/21 03/08 07:51 03/08/21 07:51 OPGN OpGen $1.94 / +0.14 (+7.78%) OpGen announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OPGN OpGen $1.94 / +0.14 (+7.78%) 03/01/21 OpGen wins Chinese NMPA approval for Curetis Unyvero System 02/16/21 Ares Genetics announces publication of study on prediction of AST results 01/05/21 OpGen's Curetis, Annar enter Unyvero distribution partnership 12/17/20 OpGen announces publication on Unyvero LRT BAL panel OPGN OpGen $1.94 / +0.14 (+7.78%) 03/02/21 Alliance Global Partners Alliance Global raises OpGen price target to $7, sees 'eventful 2021' 11/13/20 Alliance Global Partners OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners 06/09/20 Alliance Global Partners Alliance Global Partners sees OpGen preliminary data as positive 06/03/20 Alliance Global Partners OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global OPGN OpGen $1.94 / +0.14 (+7.78%) 01/13/21 OpGen reports preliminary 2020 revenue $5.2M, consensus $4.15M 01/13/21 OpGen reports preliminary Q4 revenue $1.3M, two est. $1.4M 10/15/20 OpGen reports preliminary Q3 revenue approx. $1M, one est. $1.6M
General news	Treasury Market Outlook: it's a mixed trade » 07:50 03/08/21 03/08 07:50 03/08/21 07:50 Treasury Market Outlook:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Broadcom price target raised to $540 from $460 at Loop Capital » 07:49 03/08/21 03/08 07:49 03/08/21 07:49 AVGO Broadcom $449.96 / +6.555 (+1.48%) Loop Capital analyst Cody… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AVGO Broadcom $449.96 / +6.555 (+1.48%) 03/07/21 Fly Intel: Top five weekend stock stories 03/04/21 Broadcom CFO says delivered about $3B in free cash flow in Q1 02/22/21 ForeScout appoints Kevin O'Leary chief product officer 12/21/20 Broadcom CEO sells over 14,000 common shares AVGO Broadcom $449.96 / +6.555 (+1.48%) 06:23 Today Citi Broadcom price target raised to $500 from $470 at Citi 03/05/21 JPMorgan Broadcom price target raised to $570 from $500 at JPMorgan 03/05/21 Morgan Stanley Broadcom price target raised to $538 from $521 at Morgan Stanley 03/05/21 RBC Capital Broadcom price target raised to $460 from $450 at RBC Capital AVGO Broadcom $449.96 / +6.555 (+1.48%) 03/04/21 Broadcom sees Q2 revenue approximately $6.5B, consensus $6.33B 03/04/21 Broadcom reports Q1 adjusted EPS $6.61, consensus $6.55 03/04/21 Notable companies reporting after market close 12/10/20 Broadcom sees Q1 revenue approximately $6.6B, consensus $6.52B AVGO Broadcom $449.96 / +6.555 (+1.48%) 03/06/21 Cisco, Qualcomm offer solid yield, dividend growth, Barron's says AVGO Broadcom $449.96 / +6.555 (+1.48%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Fly Intel: Pre-market Movers 03/04/21 Fly Intel: After-Hours Movers 04/05/21 Broadcom Inc. AVGO Broadcom $449.96 / +6.555 (+1.48%) 11/03/20 Unusually active option classes on open November 3rd

Hot Stocks	Ebix aims to file 2020 10-K by April 20 » 07:49 03/08/21 03/08 07:49 03/08/21 07:49 EBIX Ebix $24.88 / +0.59 (+2.43%) Ebix announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EBIX Ebix $24.88 / +0.59 (+2.43%) 02/22/21 Ebix reaffirms outlook for 2021, beyond 02/20/21 Ebix announces auditor resignation, engages outside counsel to look into matters 02/03/21 EbixCash wins long-term contract for automating, digitizing City of Pune system 11/30/20 Ebix, Data Glove Technologies sign outsourcing, joint venture agreement EBIX Ebix $24.88 / +0.59 (+2.43%) 05/12/20 Craig-Hallum Ebix shares and estimates 'have put in a floor,' says Craig-Hallum 05/12/20 BMO Capital Ebix price target lowered to $34 from $43 at BMO Capital 04/30/20 Craig-Hallum Ebix price target lowered to $75 from $80 at Craig-Hallum 03/26/20 Craig-Hallum Ebix to be top performer as investors realize stock mispriced, says Craig-Hallum EBIX Ebix $24.88 / +0.59 (+2.43%) 02/20/21 Ebix sees Q4 revenue greater than $220M, consensus $158.4M 11/09/20 Ebix not providing 2020, 2021 guidance 11/09/20 Ebix reports Q3 adj. EPS 93c, two est. 80c EBIX Ebix $24.88 / +0.59 (+2.43%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers
Hot Stocks	Camping World to expand in Delaware, Nebraska and Montana » 07:48 03/08/21 03/08 07:48 03/08/21 07:48 CWH Camping World $33.10 / +1.24 (+3.89%) Camping World Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CWH Camping World $33.10 / +1.24 (+3.89%) 03/02/21 Camping World announces deal to acquire EZ Living RV in Illinois 03/01/21 Camping World to acquire Triple A R.V. Center in Oregon 02/22/21 Camping World to acquire Lee's Family Trailer in Windham, ME, terms undisclosed 02/18/21 Camping World to acquire two dealerships in Massachusetts, one in Connecticut CWH Camping World $33.10 / +1.24 (+3.89%) 02/26/21 JPMorgan Camping World price target raised to $52 from $45 at JPMorgan 01/25/21 Northcoast Camping World upgraded to Buy from Neutral at Northcoast 01/20/21 Monness Crespi Peer's results show positive read-through for Camping World, says Monness Crespi 12/16/20 JPMorgan JPMorgan reiterates $45 target on Camping World after Lordstown pact CWH Camping World $33.10 / +1.24 (+3.89%) 02/26/21 Camping World sees FY21 adjusted EBITDA $640M-$690M 02/25/21 Camping World reports Q4 EPS 48c, consensus 26c 11/02/20 Camping World CEO confirms previously issued FY21 adjusted EBITDA target 11/02/20 Camping World raises FY20 adjusted EBITDA view to $495M-$515M from $460M-$490M 20 Aug CWH Camping World $33.10 / +1.24 (+3.89%) 12/15/20 Lordstown, Camping World to make 'special announcement,' WKBN says CWH Camping World $33.10 / +1.24 (+3.89%) 01/30/21 Charged: Tesla reports first profit miss in over a year 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades 11/02/20 Fly Intel: Wall Street's top stories for Monday CWH Camping World $33.10 / +1.24 (+3.89%) 01/28/21 Camping World put volume heavy and directionally bearish 01/22/21 Camping World call volume above normal and directionally bullish 01/21/21 Camping World call volume above normal and directionally bullish 12/16/20 Call trader flips Camping World calls for 1day loss
Hot Stocks	Pactiv Evergreen CEO John McGrath to retire, Michael King to succeed » 07:48 03/08/21 03/08 07:48 03/08/21 07:48 PTVE Pactiv Evergreen $14.85 / +0.13 (+0.88%) Pactiv Evergreen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PTVE Pactiv Evergreen $14.85 / +0.13 (+0.88%) 02/16/21 Third Point buys Upstart, exits Caesars in Q4 PTVE Pactiv Evergreen $14.85 / +0.13 (+0.88%) 03/01/21 RBC Capital Pactiv Evergreen downgraded to Sector Perform from Outperform at RBC Capital 03/01/21 RBC Capital Pactiv Evergreen downgraded to Sector Perform from Outperform at RBC Capital 02/25/21 BofA Pactiv Evergreen downgraded to Neutral from Buy at BofA 02/25/21 BofA Pactiv Evergreen downgraded to Neutral from Buy at BofA PTVE Pactiv Evergreen $14.85 / +0.13 (+0.88%) 02/25/21 Pactiv Evergreen reports Q4 EPS 10c vs. ($1.03) last year 17 Sep PTVE Pactiv Evergreen $14.85 / +0.13 (+0.88%) 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever PTVE Pactiv Evergreen $14.85 / +0.13 (+0.88%) 10/20/20 One new option listing on October 20th
Recommendations	Joint Corp. price target raised to $54 from $33 at DA Davidson » 07:45 03/08/21 03/08 07:45 03/08/21 07:45 JYNT Joint Corp. $44.06 / -0.18 (-0.41%) DA Davidson analyst Linda… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JYNT Joint Corp. $44.06 / -0.18 (-0.41%) 01/05/21 Joint Corp. acquires two regional developer territories for $2.4M JYNT Joint Corp. $44.06 / -0.18 (-0.41%) 03/05/21 Lake Street Joint Corp. price target raised to $60 from $35 at Lake Street 03/05/21 Maxim Joint Corp. price target raised to $54 from $28 at Maxim 02/25/21 B. Riley Securities Joint Corp. price target raised to $47 from $26 at B. Riley Securities 01/06/21 Craig-Hallum Joint Corp. price target raised to $38 from $26 at Craig-Hallum JYNT Joint Corp. $44.06 / -0.18 (-0.41%) 03/04/21 Joint Corp. sees FY21 revenue $73M-$77M , consensus $72.23M 03/04/21 Joint Corp. reports Q4 EPS 72c, consensus 14c 11/05/20 Joint Corp. reports Q3 EPS 11c, consensus 2c 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	Revival Gold appoints Lisa Ross as CFO » 07:45 03/08/21 03/08 07:45 03/08/21 07:45 RVLGF Revival Gold $0.00 / + (+0.00%) Revival Gold announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research RVLGF Revival Gold $0.00 / + (+0.00%) 03/01/21 Revival Gold announces results of gold mineralization at Beartrack-Arnett 02/22/21 Revival Gold announces results of Beartrack-Arnett drilling program 02/08/21 Revival Gold announces results of Beartrack-Arnett economic impact study 01/25/21 Revival Gold extends Haidee Zone with 2020 drilling results RVLGF Revival Gold $0.00 / + (+0.00%) 08/28/20 PI Financial Revival Gold price target lowered to C$1.35 from C$1.40 at PI Financial

Recommendations	Trinseo price target raised to $80 from $60 at Alembic Global » 07:43 03/08/21 03/08 07:43 03/08/21 07:43 TSE Trinseo $67.00 / +1.87 (+2.87%) Alembic Global analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TSE Trinseo $67.00 / +1.87 (+2.87%) 12/16/20 Trinseo lowers quarterly dividend to 8c from 40c 12/14/20 Trinseo sees Q4 adjusted EBITDA $137M-$152M 12/14/20 Trinseo to acquire Arkema PMMA for $1.36B, sees accretion 12/02/20 Trinseo launches new TPE pilot facility in Hsinchu, Taiwan TSE Trinseo $67.00 / +1.87 (+2.87%) 02/08/21 Citi Trinseo price target raised to $60 from $54 at Citi 12/21/20 Alembic Global Trinseo price target raised to $60 from $40 at Alembic Global 11/18/20 Morgan Stanley Trinseo upgraded to Equal Weight from Underweight at Morgan Stanley 11/18/20 Morgan Stanley Trinseo upgraded to Equal Weight from Underweight at Morgan Stanley TSE Trinseo $67.00 / +1.87 (+2.87%) 02/03/21 Trinseo sees FY21 adjusted EBITDA $400M-$450M 02/03/21 Trinseo reports Q4 adjusted EPS $1.84, consensus $1.66 11/05/20 Trinseo reports Q3 adjusted EPS $2.87, consensus $1.86 10/19/20 Trinseo sees Q3 adjusted EBITDA $100M-$104M
Initiation	Akebia initiated with an Overweight at Cantor Fitzgerald » 07:42 03/08/21 03/08 07:42 03/08/21 07:42 AKBA Akebia $3.41 / +0.09 (+2.71%) Cantor Fitzgerald analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Options AKBA Akebia $3.41 / +0.09 (+2.71%) 11/16/20 Akebia reports manuscript on global Phase 3 INNO2VATE program rationale 10/23/20 Akebia down 1% to $3.24 after reporting additional data on vadadustat 10/23/20 Akebia trading resumes 10/23/20 Akebia CEO confident vadadustat has 'straightforward path to potential approval' AKBA Akebia $3.41 / +0.09 (+2.71%) 06:17 Today H.C. Wainwright Akebia price target lowered to $6 from $9 at H.C. Wainwright 02/25/21 Piper Sandler Akebia selloff on NDA timing 'wholly misplaced,' says Piper Sandler 01/29/21 JPMorgan Akebia downgraded to Underweight from Neutral at JPMorgan 01/29/21 JPMorgan Akebia downgraded to Underweight from Neutral at JPMorgan AKBA Akebia $3.41 / +0.09 (+2.71%) 02/25/21 Akebia reports Q4 EPS (60c), consensus (40c) 11/05/20 Akebia reports Q3 EPS (42c), consensus (17c) 12 May AKBA Akebia $3.41 / +0.09 (+2.71%) 01/13/21 Researchers awarded funding to expand Akebia drug trial, UTHealth News says AKBA Akebia $3.41 / +0.09 (+2.71%) 10/12/20 Unusually active option classes on open October 12th
Hot Stocks	Cowen Group adds ESG Scores on all company-specific research reports » 07:42 03/08/21 03/08 07:42 03/08/21 07:42 COWN Cowen Group $33.97 / -0.09 (-0.26%) Cowen announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events COWN Cowen Group $33.97 / -0.09 (-0.26%) 02/24/21 Cowen Sustainable Investments reaches over $1.1B in platform assets 01/27/21 Cowen Group appoints Frank Dunlevy as vice chair, investment banking 01/26/21 Cowen Group appoints Jay Coleman as head of equity capital markets execution 01/25/21 Cowen Group appoints Kelly Wiegel to management committee COWN Cowen Group $33.97 / -0.09 (-0.26%) 12/02/20 JMP Securities Cowen Group price target raised to $32 from $25 at JMP Securities 11/23/20 Piper Sandler Cowen Group price target raised to $35 from $25 at Piper Sandler 07/22/20 Wolfe Research Cowen Group initiated with an Outperform at Wolfe Research COWN Cowen Group $33.97 / -0.09 (-0.26%) 02/11/21 Cowen Group reports Q4 EPS $2.98, consensus $2.93 10/27/20 Cowen Group reports Q3 economic EPS $1.25, consensus 38c 03/23/21 Cowen Group
Periodicals	Harley-Davidson to roll out certified pre-owned bike program, Reuters reports » 07:42 03/08/21 03/08 07:42 03/08/21 07:42 HOG Harley-Davidson $34.95 / -0.155 (-0.44%) In an effort to attract… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HOG Harley-Davidson $34.95 / -0.155 (-0.44%) 02/17/21 Harley-Davidson names Edel O'Sullivan as Chief Commercial Officer 02/02/21 Harley-Davidson to focus electric strategy through a separate division 02/02/21 Harley-Davidson sees $20M of restructuring charges early in 2021 02/02/21 Harley-Davidson exploring partnerships for electric bike HOG Harley-Davidson $34.95 / -0.155 (-0.44%) 02/03/21 BMO Capital Harley-Davidson price target lowered to $40 from $46 at BMO Capital 02/03/21 Citi Harley-Davidson price target lowered to $39 from $47 at Citi 01/29/21 Northcoast Harley-Davidson downgraded to Neutral after 'mixed' checks at Northcoast 01/29/21 Fly Intel: Top five analyst downgrades HOG Harley-Davidson $34.95 / -0.155 (-0.44%) 02/02/21 Harley-Davidson reports Q4 adjusted EPS (44c), consensus 14c 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 10/27/20 Harley-Davidson not providing FY20 guidance HOG Harley-Davidson $34.95 / -0.155 (-0.44%) 11/12/20 Harley-Davidson plans to leave India, NY Times reports 09/25/20 Harley-Davidson nearing distribution deal with Hero MotoCorp, Reuters reports HOG Harley-Davidson $34.95 / -0.155 (-0.44%) 02/08/21 Fly Insider: Harley-Davidson, Amgen among week's notable insider trades 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday 02/02/21 Fly Intel: Pre-market Movers HOG Harley-Davidson $34.95 / -0.155 (-0.44%) 12/10/20 Unusually active option classes on open December 10th 11/23/20 Unusually active option classes on open November 23rd 11/12/20 Harley Davidson put volume heavy and directionally bearish 10/30/20 Harley Davidson put volume heavy and directionally bearish
Hot Stocks	Orgenesis enters agreement with Dong-a University Hospital, Cure Therapeutics » 07:41 03/08/21 03/08 07:41 03/08/21 07:41 ORGS Orgenesis $7.13 / +0.11 (+1.57%) Orgenesis, Dong-a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Earnings On The Fly ORGS Orgenesis $7.13 / +0.11 (+1.57%) 09/29/20 Orgenesis to acquire Koligo for $15M ORGS Orgenesis $7.13 / +0.11 (+1.57%) 09/29/20 Fly Intel: Pre-market Movers

Events

Earnings calls, analyst events, roadshows and more

NERV
Today at 08:30

Minerva - NERV Conference Calls
CI
Today at 08:30

CIGNA Corporation Firm Sponsored Meetings
ABCM
Today at 09:00

Abcam - ABCM Conference Calls
Today at 10:00

Wholesale Inventories (Preliminary) M/M: January 2021 Government Event
FOLD
Today at 10:00

Amicus - FOLD Conference Calls
NINE
Today at 10:00

Nine Energy Service - NINE Conference Calls
MGIC
Today at 10:00

Magic Software - MGIC Conference Calls
PERI
Today at 10:00

Perion Network Ltd. Firm Sponsored Meetings

Virtual Meeting
RDNT
Today at 10:30

RadNet - RDNT Conference Calls
RP
Today at 11:00

RealPage, Inc. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CPNG X CPNG Coupang IPO Managers: Goldman Sachs, Allen & Co., JPMorgan & BofA, HSBC, Deutsche Bank, UBS, MIZU, CLSA $27.00-30.00 120M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HAYW X HAYW Hayward IPO Managers: BofA, Goldman Sachs & Nomura, Credit Suisse, Morgan Stanley, Baird, Guggenheim, Jefferies, BMO Capital, KeyBanc, William Blair, HOUL, Moelis $17.00-19.00 40.278M Shares
Thurs	JOAN X JOAN Joann IPO Managers: BofA & Credit Suisse, Guggenheim, Barclays, Wells Fargo, Piper Sandler, William Blair, HOUL, Telsey Advisory, Loop Capital, Ramirez $15.00-17.00 10.94M Shares
Fri	No deals

View All Syndicate Announcements »

Albemarle price target raised to $177 from $140 at Argus

TODAY'S FREE FLY STORIES

Get Full Fly Access